Loading insider details...
Beta
Latest Form 4 (Jun 8, 2026): Exercise/Conversion of 11,580 ACRS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 8, 2026 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 11,580 | n/a |
| Jun 9, 2025 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 4,793 | n/a |
| Jun 21, 2024 | Clearside Biomedical, Inc. (CLSD) | Grant/Award | 45,000 | n/a |
| Jun 10, 2024 | Aclaris Therapeutics, Inc. (ACRS) | Grant/Award | 15,750 | n/a |
| Jun 4, 2024 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 4,660 | n/a |
| Sep 22, 2023 | Clearside Biomedical, Inc. (CLSD) | Exercise/Conversion | 22,727 | $9.1K |
| Jul 7, 2023 | STRATA Skin Sciences, Inc. (SSKN) | Grant/Award | 36,408 | $37.5K |
| Jun 23, 2023 | Clearside Biomedical, Inc. (CLSD) | Grant/Award | 30,000 | n/a |
| Jun 5, 2023 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 4,507 | n/a |
| Jun 24, 2022 | Clearside Biomedical, Inc. (CLSD) | Grant/Award | 30,000 | n/a |